SARS-CoV2 infection in symptomatic patients: interest of serological tests and predictors of mortality: experience of DR Congo
- PMID: 34983411
- PMCID: PMC8724652
- DOI: 10.1186/s12879-021-07003-9
SARS-CoV2 infection in symptomatic patients: interest of serological tests and predictors of mortality: experience of DR Congo
Abstract
Background: In symptomatic patients, the diagnostic approach of COVID-19 should be holistic. We aimed to evaluate the concordance between RT-PCR and serological tests (IgM/IgG), and identify the factors that best predict mortality (clinical stages or viral load).
Methods: The study included 242 patients referred to the University hospital of Kinshasa for suspected COVID-19, dyspnea or ARDS between June 1st, 2020 and August 02, 2020. Both antibody-SARS-CoV2 IgM/IgG and RT-PCR method were performed on the day of admission to hospital. The clinical stages were established according to the COVID-19 WHO classification. The viral load was expressed by the CtN2 (cycle threshold value of the nucleoproteins) and the CtE (envelope) genes of SARS- CoV-2 detected using GeneXpert. Kappa test and Cox regression were used as appropriate.
Results: The GeneXpert was positive in 74 patients (30.6%). Seventy two patients (29.8%) had positive IgM and 34 patients (14.0%) had positive IgG. The combination of RT-PCR and serological tests made it possible to treat 104 patients as having COVID-19, which represented an increase in cases of around 41% compared to the result based on GeneXpert alone. The comparison between the two tests has shown that 57 patients (23.5%) had discordant results. The Kappa coefficient was 0.451 (p < 0.001). We recorded 23 deaths (22.1%) among the COVID-19 patients vs 8 deaths (5.8%) among other patients. The severe-critical clinical stage increased the risk of mortality vs. mild-moderate stage (aHR: 26.8, p < 0.001). The values of CtE and CtN2 did not influence mortality significantly.
Conclusion: In symptomatic patients, serological tests are a support which makes it possible to refer patients to the dedicated COVID-19 units and treat a greater number of COVID-19 patients. WHO Clinical classification seems to predict mortality better than SARS-Cov2 viral load.
Keywords: COVID-19; Concordance; Mortality; RT-PCR; Serological tests; Symptomatic patients.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be considered as a potential conflict of interest.
Figures
Similar articles
-
Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional study.PLoS One. 2022 Apr 14;17(4):e0266923. doi: 10.1371/journal.pone.0266923. eCollection 2022. PLoS One. 2022. PMID: 35421183 Free PMC article.
-
Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: Perspectives for public health.Environ Res. 2021 Apr;195:110793. doi: 10.1016/j.envres.2021.110793. Epub 2021 Jan 27. Environ Res. 2021. PMID: 33508260 Free PMC article.
-
Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.J Med Internet Res. 2020 Oct 30;22(10):e19152. doi: 10.2196/19152. J Med Internet Res. 2020. PMID: 33031048 Free PMC article.
-
Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10208-10218. doi: 10.26355/eurrev_202010_23243. Eur Rev Med Pharmacol Sci. 2020. PMID: 33090430 Review.
-
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
Cited by
-
Interest of Chest CT to Assess the Prognosis of SARS-CoV-2 Pneumonia: An In-Hospital-Based Experience in Sub-Saharan Africa.Pulm Med. 2024 Apr 25;2024:5520174. doi: 10.1155/2024/5520174. eCollection 2024. Pulm Med. 2024. PMID: 38699403 Free PMC article.
-
Clinical progression and outcomes of patients hospitalized with COVID-19 in humanitarian settings: A prospective cohort study in South Sudan and Eastern Democratic Republic of the Congo.PLOS Glob Public Health. 2022 Oct 19;2(10):e0000924. doi: 10.1371/journal.pgph.0000924. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962562 Free PMC article.
-
Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo.Epidemiol Infect. 2023 Feb 1;151:e24. doi: 10.1017/S0950268823000158. Epidemiol Infect. 2023. PMID: 36775822 Free PMC article.
References
-
- Sahin AR, Erdogan A, Agaoglu PM, Dineri Y, Cakirci AY, Senel ME. 2019 Novel Coronavirus (COVID-19) outbreak: a review of the current literature. EJMO. 2020;4(1):1–7.
-
- World Health Organization (WHO). Clinical management of COVID-19. WHO/2019-nCoV/clinical/2020.5.
-
- Chan JFW, Yip CCY, To KKW, Tang THC, Wong SCY, Leung KH, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J Clin Microbiol. 2020;58:e00310–e320. doi: 10.1128/JCM.00310-20. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous